Reading HP? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HP free→Reading HP? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HP free→QuarterlyIQ Insights · HP
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 3 valuation methods, at three horizons. Current price $39.25. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer EV/EBITDA | 12M | $38.46 | 8.6 | 6.56 | TTM | high |
| Peer P/FCF | 12M | $44.12 | 17.2 | 2.56 | TTM | high |
| Peer P/S | 12M | $65.22 | 1.8 | 36.47 | TTM | high |
| Peer P/FCF | 3Y | $50.44 | 17.2 | 2.93 | Hist. CAGR(prov.) | high |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
| Peer P/S | 3Y | $91.98 | 1.8 | 51.44 | Analyst | high |
| Peer P/FCF | 5Y | $55.14 | 17.2 | 3.20 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $115.67 | 1.8 | 64.69 | Analyst | high |